Home › Breast Cancer › New Jersey › Clifton
Breast Cancer clinical trials in Clifton, NJ
12 studies for Breast Cancer are looking for participants at sites in and around Clifton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RecruitingPhase 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack · 7 mi away
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack · 7 mi away
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RecruitingPhase 3
- John Theurer Ctr-Hackensack UMC, Hackensack · 7 mi away
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
RecruitingPhase 2
- Hackensack Meridian Health, Hackensack · 7 mi away
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RecruitingPhase 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
RecruitingPhase 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Hackensack University Medical Center, Hackensack · 7 mi away
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RecruitingPhase 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi away
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RecruitingPhase 3
- Hackensack University Medical Center, Hackensack · 7 mi away
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecruitingPhase 1
- Hackensack University Medical Center, Hackensack · 7 mi away
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RecruitingObservational study
- John Theurer Cancer Center, Hackensack · 7 mi away
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Clifton
- Non-Small Cell Lung Cancer24 studies
- Cancer (all types)15 studies
- Multiple Myeloma14 studies
- Metastatic Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Ovarian Cancer11 studies
- Lung Cancer10 studies
- Endometrial Cancer8 studies
- Triple-Negative Breast Cancer8 studies
- Colorectal Cancer8 studies
- Head and Neck Squamous Cell Carcinoma8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.